Form 4: Rocket Lab Director Sells Shares Under 10b5-1 Plan

Rocket Lab Corp Director Merline Saintil sold 5,000 shares of common stock on December 17, 2025, through a pre-arranged Rule 10b5-1 trading plan.

Summary

• Merline Saintil, a Director of Rocket Lab Corp (RKLB), reported the sale of 5,000 shares of common stock.
• The transactions occurred on December 17, 2025, and were executed automatically pursuant to a Rule 10b5-1 trading plan adopted on September 17, 2025.
• The shares were sold in multiple transactions at weighted-average prices ranging from $53.8164 to $56.48.
• Specifically, 2,533 shares were sold at a weighted-average price of $53.8164 (ranging from $53.3600 to $54.2900).
• Another 1,767 shares were sold at a weighted-average price of $54.824 (ranging from $54.3700 to $55.3500).
• An additional 500 shares were sold at a weighted-average price of $55.668 (ranging from $55.3700 to $55.8600).
• Finally, 200 shares were sold at a weighted-average price of $56.48 (ranging from $56.3700 to $56.5900).
• Following these transactions, Merline Saintil beneficially owns 393,529 shares of Rocket Lab Corp common stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale executed under a pre-arranged 10b5-1 trading plan. Such transactions are generally considered neutral as they are non-discretionary and do not typically reflect new information about the company's performance or prospects.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a non-discretionary, scheduled transaction rather than a reaction to recent company performance or news.

Negatives

• A director's sale of shares, even if pre-planned, reduces insider ownership, which can sometimes be perceived negatively by the market.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing reports a routine insider transaction and does not provide specific insights into broader industry trends or competitive landscape for the aerospace and defense sector in which Rocket Lab operates.

Stakeholder Impact

• Shareholders: A director's reduction in direct share ownership, though pre-planned, slightly decreases the alignment of interests between the director and other shareholders. However, the impact is minimal given the routine nature of 10b5-1 sales and the remaining substantial holding.

Next Steps

• The Reporting Person undertakes to provide the Registrant, any securityholder, or the SEC Staff, upon request, full information regarding the number of shares sold at each separate price within the reported ranges.

Key Dates

Recommendation

The filing details a pre-scheduled sale of common stock by a director under a Rule 10b5-1 trading plan. This is a routine transaction and does not inherently signal a change in the company's fundamentals or future prospects, thus a 'hold' recommendation is maintained based solely on this filing.

Keywords

Rocket Lab, RKLB, Merline Saintil, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Director